The Pfizer whistleblower in my story "Pfizer whistleblower accuses company of using sales force to illegally market new AIDS-drug before FDA approval" has just forwarded the response she received from an agent

::::::::

The Pfizer whistleblower in my story "Pfizer whistleblower accuses company of using sales force to illegally market new AIDS-drug before FDA approval" has contacted the Office of Inspector General at the Department of Health and Human Services with her concerns about what she alleges is Pfizer's illegal premarketing of the HIV/AIDS drug maraviroc. The Pfizer whistleblower just forwarded the response she received from an agent at the OIG:

I just wanted to send you a quick note to let you know that I have
received your emails. I am still in trial, but I do want to meet with
you in the next week or two. I will contact you (probably later next
week) to set up a time to meet up. If you have any additional
informaiton, feel free to send it along.

Thanks!

Special Agent NAME REDACTED
U.S. Department of Health and Human Services
Office of Inspector General
50 Kennedy Plaza, Suite 750
Providence, RI 02903
Phone: REDACTED
Fax: REDACTED

One reason the OIG is interested in this situation is that Pfizer has been forced to sign not just one, but two corporate integrity agreements (CIA) with this agency (download here), promising to conduct their business in an ethical manner.

Pfizer is obligated to notify the OIG of all "reportable events" within 30 days, such as suspicions of any illegal behavior. If Pfizer would not do this they would be in violation of the terms of the CIA and could receive fines, or, at worst, be excluded from federal health care programs.

Authors Bio:
Peter Rost M.D. Peter Rost, M.D., is a former Vice President of Pfizer. He is the author of "The Whistleblower, Confessions of a Healthcare Hitman" and "Killer Drug." He also writes the daily Pharma Law Blog and the Pharma Expert Witness Blog.